Addiction Medicine: Closing the Gap between Science and Practice

(lu) #1

Rounsaville, B. J. (2004). Treatment of cocaine dependence and depression. Biological Psychiatry,
56 (10), 803-809.


Rounsaville, B. J., Kosten, T., & Kleber, H. (1985). Success and failure at outpatient opioid
detoxification. Evaluating the process of clonidine- and methadone-assisted withdrawal. Journal of
Nervous & Mental Disease, 173(2), 103-110.


Rowe, C. L., & Liddle, H. A. (2003). Substance abuse. Journal of Marital & Family Therapy, 29(1), 97-
120.


Rowe, C. L., Liddle, H. A., Greenbaum, P. E., & Henderson, C. E. (2004). Impact of psychiatric
comorbidity on treatment of adolescent drug abusers. Journal of Substance Abuse Treatment, 26(2),
129-140.


Roy, A. K., & Miller, M. M. (2012). The medicalization of addiction treatment professionals. Journal of
Psychoactive Drugs, 44(2), 1-12.


Roy, K., & Miller, M. (2010). Parity and the medicalization of addiction treatment. Journal of
Psychoactive Drugs, 42(2), 115-121.


RTI International. (2009). 2008 Department of Defense survey of health related behaviors among active
duty military personnel. A component of the Defense Lifestyle Assessment Program (DLAP). Ann
Arbor, MI: Author.


Rubinstein, M. L., Benowitz, N. L., Auerback, G. M., & Moscicki, A. B. (2009). Withdrawal in
adolescent light smokers following 24-hour abstinence. Nicotine & Tobacco Research, 11(2), 185-
189.


Rubinstein, M. L., Luks, T. L., Moscicki, A. B., Dryden, W., Rait, M. A., & Simpson, G. V. (2011).
Smoking-related cue-induced brain activation in adolescent light smokers. Journal of Adolescent
Health, 48(1), 7-12.


Rubinstein, M. L., Thompson, P. J., Benowitz, N. L., Shiffman, S., & Moscicki, A.-B. (2007). Cotinine
levels in relation to smoking behavior and addiction in young adolescent smokers. Nicotine &
Tobacco Research, 9(1), 129-135.


Rubio, G., Ponce, G., Rodriguez-Jiminez, R., Jimenez-Arriero, A., Hoenicka, J., & Palomo, T. (2005).
Clinical predictors of response to naltrexone in alcoholic patients: Who benefits most from treatment
with naltrexone? Alcohol & Alcoholism, 40(3), 227-2333.


Ruiz v. Estelle, 503 F. Supp. 1265 (S.D. Tex. 1980).


Ruiz, P. & Langrod, J. G. (2009). Hispanic Americans. In J. Lowinson, P. Ruiz, R. B. Millman, & J. G.
Langrod (Eds.), Substance abuse: A comprehensive textbook (pp. 1103-1112). Baltimore, MD:
Williams and Wilkins.


Ruiz, P., Varner, R. V., Small, D. R., & Johnson, B. A. (1999). Ethnic differences in the neuroleptic
treatment of schizophrenia. Psychiatric Quarterly, 70(2), 163-172.


Rumpf, H. J., Hapke, U., Hill, A., & John, U. (1997). Development of a screening questionnaire for the
general hospital and general practices. Alcoholism: Clinical & Experimental Research, 21(5), 894-
898.


Russell, C., Davies, J. B., & Hunter, S. C. (2011). Predictors of addiction treatment providers' beliefs in
the disease and choice models of addiction. Journal of Substance Abuse & Treatment, 40(2), 150-164.


Russell, L. B. (2007). Prevention's potential for slowing the growth of medical spending. Washington,
DC: Rutgers University, Institute of Health, National Coalition on Health Care.

Free download pdf